SQNM Sequenom, Inc. featured news, full reports, and detailed charts
Sequenom, Inc. (SQNM) Wrap Up:
All statements in this report that are not historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act. These forward-looking statements can generally be identified as such because the context of the statement will include words such as “may,” “will,” “intend,” “plans,” “believes,” “anticipates,” “expects,” “estimates,” “predicts,” “potential,” “continue,” “opportunity,” “goals,” or “should,” the negative of these words or words of similar import. Similarly, statements that describe our future plans, strategies, intentions, expectations, objectives, goals or prospects are also forward-looking statements. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0001193125-08-058935.html#FIS_BUSINESS"www.sequenom.com
248 Employees
Founded in 1994
Sequenom Inc. (SQNM:NASDAQ)
LAST $3.13 USD
CHANGE TODAY +0.03 0.97%
VOLUME 1.3M
As of 4:00 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Sequenom Inc. (SQNM)
|
OPEN
$3.13
|
PREVIOUS CLOSE
$3.10
|
|
|
DAY HIGH
$3.18
|
DAY LOW
$3.10
|
|
|
52 WEEK HIGH
01/22/09 - $25.99
|
52 WEEK LOW
10/30/09 - $2.55
|
|
|
MARKET CAP
191.7M
|
AVERAGE VOLUME 3 mo
1.7M
|
|
|
DILUTED EPS TTM
$-1.14
|
SHARES OUTSTANDING
61.2M
|
|
|
SQNM Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
related news
Stocks Fall as Consumer Confidence Dips
09/29/2009 5:00 PM ET
Stocks End Mixed after Chrysler Bankruptcy
04/30/2009 4:25 PM ET
Analyst Actions: Sequenom, Cadence Design, Sunpower
04/30/2009 11:59 AM ET
Marcial: Best Biotechs for 2009
01/12/2009 12:01 AM ET
SQNM Top Compensated Officers
Dr. Harry Stylli M.B.A., Ph.D.
President and Executive Director
Age: 47
Total Annual Compensation: $441.0K
Mr. Paul W. Hawran
Chief Financial Officer and Principal Account...
Age: 56
Total Annual Compensation: $308.5K
Dr. Elizabeth Dragon Ph.D.
Senior Vice President of Research & Developme...
Age: 60
Total Annual Compensation: $279.1K
Mr. Clarke Neumann J.D.
Vice President, Assistant Secretary and Gener...
Age: 45
Total Annual Compensation: $250.0K
Mr. Steven Owings
Vice President of Commercial Development of P...
Age: 56
Total Annual Compensation: $213.2K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for Sequenom Inc. (SQNM)
Sequenom Inc. to Report Q3, 2009 Results on November 09, 2009
11/4/2009
Sequenom Inc. announced that they will report Q3, 2009 results after the market closes on November 09, 2009.
Sequenom Inc., Q3 2009 Earnings Call, Nov--09-2009
11/4/2009
Sequenom Inc., Q3 2009 Earnings Call, Nov-09-2009
Sequenom Inc. expected to Report Fiscal Year 2009 Results on February 8, 2010. This event was calculated by Capital IQ (Created on November 4, 2009).
11/4/2009
Sequenom Inc. expected to Report Fiscal Year 2009 Results on February 8, 2010. This event was calculated by Capital IQ (Created on November 4, 2009).
SQNM Competitors
| Company | Last | Change |
| Biotage AB | kr6.25 SEK | +0.05 |
| CombiMatrix Corp | $6.14 USD | -0.18 |
| Nanosphere Inc | $6.26 USD | +0.13 |
| Orchid Cellmark Inc | $1.57 USD | 0.00 |
| Transgenomic Inc | $0.74 USD | +0.04 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | SQNM | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 4.9x |
|
| Price/Book | 2.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 3.5x |
|
|
SQNM |
||
|
SQNM transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Sequenom, Inc.
Would you like to leave a comment about Sequenom, Inc. SQNM
Find out what social network information about Sequenom, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Sequenom, Inc. there is more great information available at Realpennies.com
